FibromyalgiaSupport.com is now ProHealth.com


Fibromyalgia Resource

Fibromyalgia Information from FibromyalgiaSupport.com
ProHealth Weekly Web Special
HOME Library Bulletins Fibromyalgia Treatment and Research Email bulletins STORE Fibromyalgia Treatment Store Community FibromyalgiaCommunity
Health Watch Newsletter The Latest News Articles The Latest Abstracts The Latest Drug News
Search Our Site
 
Home
Fibromyalgia Resources
E-mail Bulletin
Store
Community
About Us
Your Support Funds Research & Advocacy

Abstract: The prevalence of fibromyalgia in women aged 20-64 in Turkey


Fibromyalgiasupport.com

08-15-2005

Advertisement
Scand J Rheumatol. 2005 Mar-Apr;34(2):140-4.

Topbas M, Cakirbay H, Gulec H, Akgol E, Ak I, Can G.

Department of Public Health, Faculty of Medicine, Karadeniz Technical University, Trabzon, Turkey. mtopbas@meds.ktu.edu.tr

OBJECTIVE: The objectives of this study were to determine the prevalence of fibromyalgia syndrome (FMS) in women aged 20-64 in the city of Trabzon, Turkey, and to evaluate associated demographic variables.

METHODS: A minimum of 1825 subjects eligible for the study was calculated, and 2000 subjects were eventually planned for inclusion. Of these, 1930 subjects participated in the screening phase (a participation rate of 96.5%). The screening protocol included several interview items that have been defined as components of FMS. Subjects were also asked questions concerning demographics. Individuals with positive screening results were invited to be examined by a specialist in physical medicine and rehabilitation in order to confirm or exclude FMS using the 1990 American College of Rheumatology (ACR) classification criteria.

RESULTS: Seventy of the 1930 women were diagnosed with FMS. The prevalence of fibromyalgia was 3.6% (95% CI 2.8-4.4). The prevalence was highest in the 50-59 age group (10.1%, 95% CI 8.8-11.4), in the uneducated (10.7%, 95% CI 9.3-12.1), in the widowed (8.8%, 95% CI 7.5-10.1), and in subjects with an annual household income of < USD 2000 (7.3%, 95% CI 6.1-8.5).

CONCLUSION: This cross-sectional study is the first report of the prevalence of FMS in Turkey. These data will assist decision-making in the health system.

PMID: 16095011 [PubMed - in process]

  Newsletter SignUp Discuss (0 comments) Email Article Print Page
Related Articles:
Abstract: Increased Expression of N-Methyl-D-Aspartate Receptor Subunit 2D in the Skin of Patients with Fibromyalgia
Rating of 3
Abstract: Fibromyalgia - new concepts of pathogenesis and treatment
Rating of 3
Abstract: Glial cell line-derived neurotrophic factor and somatostatin levels in cerebrospinal fluid of patients affected by chronic migraine and fibromyalgia
Rating of 3
Abstract: Fibromyalgia Frequency in Hepatitis B Carriers
Rating of 2.9
Abstract: Fibromyalgia and Gaucher's disease
Rating of 3

Every purchase funds research, donations and the community resources provided within our website.

Supports the natural detox process
Organic Total Body Cleanse by RenewLife

Bioactive meal replacement support for detox
Fast & Be Clear from Allergy Research

Exfoliate and rejuvenate your skin
Infinity Natural Bristle Brush

Package of 5 Tea Bags
Infinity Bath Teabags

Sit down and turn on the sun
Verilux® HappyLite® Mini

At ProHealth we believe in "commerce with compassion."

Weekly Special





[ Be the first to comment on this article ]
DISCUSS THIS ARTICLE  (0 existing comments)
Post a Comment
 
transparent gif transparent gif transparent gif

Home | Library | Email Bulletins | Store | Community


ProHealth's FibromyalgiaSupport.com- The World's Largest Fibromyalgia Website!
Email US or Call US at 1-800-366-6056
Monday-Friday, 7 a.m.-5 p.m. PST
International Callers can reach us at 001.805.564.3064
Copyright © 2008 ProHealth, Inc.
About us, Affiliates, Careers, Contact us, Privacy, 30-day Money Back Guarantee